SAMANTHA PAULINE: Open Payments
NPI 1962129809 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,594 in 137 payments from 27 companies in 2025. Trend: 2023 $3,449 · 2024 $3,561 · 2025 $2,594
Food & beverage: $2,515Education: $79
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $517 |
| UCB, Inc. | 12 | $248 |
| Novartis Pharmaceuticals Corporation | 9 | $178 |
| Genentech USA, Inc. | 12 | $147 |
| CATALYST PHARMACEUTICALS, INC. | 6 | $146 |
| Eisai Inc. | 11 | $145 |
| ARGENX US, INC. | 7 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $119 |
| TG Therapeutics, Inc. | 7 | $107 |
| Neurelis, Inc. | 4 | $93 |
Products named: UBRELVY, KESIMPTA, Ocrevus Zunovo, FYCOMPA, Leqembi, BOTOX, Rystiggo, HYQVIA.
Industry payments across KY — which companies pay providers there.
